Clinical Trial Detail

NCT ID NCT02648724
Title Sym015 (Anti-MET) in Patients With Advanced Solid Tumor Malignancies
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Symphogen A/S
Indications

Advanced Solid Tumor

lung non-small cell carcinoma

Therapies

SYM015

Age Groups: adult senior

No variant requirements are available.